Shree Ganesh Remedies Ltd

NEW
NSE:SGRL ()   Ordinary Shares
₹ 518.35 (0%) Aug 19
37.79
P/B:
4.12
Market Cap:
₹ 6.71B ($ 70.08M)
Enterprise V:
₹ 6.76B ($ 70.57M)
Volume:
3.85K
Avg Vol (2M):
3.85K
Trade In:

Business Description

Shree Ganesh Remedies Ltd

ISIN : INE414Y01015

Share Class Description:

NSE:SGRL: Ordinary Shares

Total Employee Number:

149
Compare
Compare
Traded in other countries / regions
540737.India
IPO Date
2026-08-17
Description
Shree Ganesh Remedies Ltd manufactures drug intermediates, chemicals, and specialty fine chemicals for the pharmaceutical industry. The company offers pharmaceutical and specialty chemical products, including Trityl chloride, Furoyl chloride, and Dinitolmide. The company's business falls under the primary segment of Bulk Drug Intermediaries.
Name Current Vs Industry Vs History
Cash-To-Debt
0.85
Equity-to-Asset
0.79
Debt-to-Equity
0.19
Debt-to-EBITDA
0.81
Interest Coverage
6.89
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
10.34
Distress
Grey
Safe
Beneish M-Score
-1.51
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate
4.6
3-Year EBITDA Growth Rate
10.9
3-Year EPS without NRI Growth Rate
-0.6
3-Year Book Growth Rate
22.4

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
3.96
Quick Ratio
2.85
Cash Ratio
1.2
Days Inventory
198.02
Days Sales Outstanding
88.4
Days Payable
72.38

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield %
0.29

Financials

NSE:SGRL's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Shree Ganesh Remedies Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ₹) 1,092.858
EPS (TTM) (₹) 13.83
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % -
14-Day RSI -
14-Day ATR (₹) -
20-Day SMA (₹) -
12-1 Month Momentum % -
52-Week Range (₹) 512 - 532.1
Shares Outstanding (Mil) 12.84

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Shree Ganesh Remedies Ltd Filings

Filing Date Document Date Form
No Filing Data

Shree Ganesh Remedies Ltd Stock Events

Financials Calendars
Event Date Price (₹)
No Event Data

Shree Ganesh Remedies Ltd Frequently Asked Questions

What is Shree Ganesh Remedies Ltd(NSE:SGRL)'s stock price today?
The current price of NSE:SGRL is ₹518.35. The 52 week high of NSE:SGRL is ₹532.10 and 52 week low is ₹512.00.
When is next earnings date of Shree Ganesh Remedies Ltd(NSE:SGRL)?
The next earnings date of Shree Ganesh Remedies Ltd(NSE:SGRL) is .
Does Shree Ganesh Remedies Ltd(NSE:SGRL) pay dividends? If so, how much?
Shree Ganesh Remedies Ltd(NSE:SGRL) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Shree Ganesh Remedies Ltd

No articles.